» Articles » PMID: 25649828

The Rationale for Exercise in the Management of Pain in Parkinson's Disease

Overview
Publisher Sage Publications
Specialty Neurology
Date 2015 Feb 5
PMID 25649828
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Pain is a distressing non-motor symptom experienced by up to 85% of people with Parkinson's disease (PD), yet it is often untreated. This pain is likely to be influenced by many factors, including the disease process, PD impairments as well as co-existing musculoskeletal and/or neuropathic pain conditions. Expert opinion recommends that exercise is included as one component of pain management programs; however, the effect of exercise on pain in this population is unclear. This review presents evidence describing the potential influence of exercise on the pain-related pathophysiological processes present in PD. Emerging evidence from both animal and human studies suggests that exercise might contribute to neuroplasticity and neuro-restoration by increasing brain neurotrophic factors, synaptic strength and angiogenesis, as well as stimulating neurogenesis and improving metabolism and the immune response. These changes may be beneficial in improving the central processing of pain. There is also evidence that exercise can activate both the dopaminergic and non-dopaminergic pain inhibitory pathways, suggesting that exercise may help to modulate the experience of pain in PD. Whilst clinical data on the effects of exercise for pain relief in people with PD are scarce, and are urgently needed, preliminary guidelines are presented for exercise prescription for the management of central neuropathic, peripheral neuropathic and musculoskeletal pain in PD.

Citing Articles

Exercise Training for Chronic Pain: Available Evidence, Current Recommendations, and Potential Mechanisms.

Ninneman J, Roberge G, Stegner A, Cook D Curr Top Behav Neurosci. 2024; 67:329-366.

PMID: 39120812 DOI: 10.1007/7854_2024_504.


A Mixed Methods Approach to Explore the Experience of Pain and Its Management in People with Parkinson's Disease.

Nguy V, Brady B, Hassett L, Canning C, Elliott J, Allen N Parkinsons Dis. 2024; 2024:8515400.

PMID: 38828214 PMC: 11144069. DOI: 10.1155/2024/8515400.


Pain and the Non-Pharmacological Management of Pain in People with Parkinson's Disease.

Allen N, Romaliiska O, Naisby J J Parkinsons Dis. 2024; 14(s1):S65-S80.

PMID: 38457146 PMC: 11380256. DOI: 10.3233/JPD-230227.


What is available to support pain management in Parkinson's: a scoping review protocol.

Parkinson M, Ryan C, Avery L, Hand A, Ramaswamy B, Jones J Int J Equity Health. 2023; 22(1):244.

PMID: 37993895 PMC: 10666362. DOI: 10.1186/s12939-023-02046-7.


Research trends and hotspots of neuropathic pain in neurodegenerative diseases: a bibliometric analysis.

Fu Y, Gong C, Zhu C, Zhong W, Guo J, Chen B Front Immunol. 2023; 14:1182411.

PMID: 37503342 PMC: 10369061. DOI: 10.3389/fimmu.2023.1182411.


References
1.
Thompson P, Buchner D, Pina I, Balady G, Williams M, Marcus B . Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition,.... Circulation. 2003; 107(24):3109-16. DOI: 10.1161/01.CIR.0000075572.40158.77. View

2.
Olanow C, Schapira A . Therapeutic prospects for Parkinson disease. Ann Neurol. 2013; 74(3):337-47. DOI: 10.1002/ana.24011. View

3.
Hughes A, Daniel S, Kilford L, Lees A . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992; 55(3):181-4. PMC: 1014720. DOI: 10.1136/jnnp.55.3.181. View

4.
Frazzitta G, Balbi P, Maestri R, Bertotti G, Boveri N, Pezzoli G . The beneficial role of intensive exercise on Parkinson disease progression. Am J Phys Med Rehabil. 2013; 92(6):523-32. DOI: 10.1097/PHM.0b013e31828cd254. View

5.
Stephens B, Mueller A, Shering A, Hood S, Taggart P, Arbuthnott G . Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience. 2005; 132(3):741-54. DOI: 10.1016/j.neuroscience.2005.01.007. View